BioSpace News Archive

Business

Soligenix Enters into Exclusive Option Agreement with Silk Road Therapeutics for Rights to Topical Pentoxifylline Designed to Treat Behçet’s Disease

Soligenix, Inc. today announced that it has entered into an exclusive option agreement with Silk Road Therapeutics, a privately-held company.

May 1, 2023
·
10 min read
InspireMD Announces Successful First-in-Human Procedure Utilizing CGuard Prime, its Next Generation Carotid Artery Stent (CAS) Platform

InspireMD, Inc., developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, announced that the first carotid artery disease patient has been treated utilizing CGuard Prime, the company’s next generation CAS stent platform.

May 1, 2023
·
6 min read
Biotech Bay

Mainz Biomed to Participate in Digestive Disease Week 2023

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced its participation in the annual Digestive Disease Week conference being held this year May 6-9 in Chicago, IL.

May 1, 2023
·
6 min read
BioMidwest

Exact Sciences to participate in May 2023 investor conference

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, announced that company management will participate in the following conference and invited investors to participate by webcast.

May 1, 2023
·
1 min read
Business

Ovid Therapeutics Announces Collaboration with Graviton Bioscience, Proven Developers of Selective ROCK2 Inhibitors

Ovid Therapeutics Inc. and Graviton Bioscience Corporation announced a collaboration agreement to innovate novel medicines that they believe will significantly change the treatment paradigm for serious, rare neurological diseases.

May 1, 2023
·
8 min read
Biotech Bay

IDEAYA Biosciences to Participate in Upcoming May 2023 Investor Relations Event

IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor relations event.

May 1, 2023
·
2 min read
BioMidwest

Rockwell Medical Announces Global Expansion into the United Arab Emirates

Rockwell Medical, Inc. announced that the Company expanded its geographic footprint by entering a long-term supply agreement with Global Medical Supply Chain LLC to begin selling Rockwell’s hemodialysis concentrates products into the United Arab Emirates.

May 1, 2023
·
4 min read
Pharm Country

Eagle Pharmaceuticals Granted Unique J-Code for Byfavo®¹ (remimazolam for injection) from CMS

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that the Centers for Medicare & Medicaid Services (“CMS”) has established a unique, product-specific billing code for Byfavo® 1 (remimazolam for injection).

May 1, 2023
·
12 min read
Business

Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023

Cara Therapeutics, Inc. today announced the Company will host a conference call and live audio webcast on Monday, May 15, 2023, at 4:30 p.m. ET to report first quarter 2023 financial results and provide a corporate update.

May 1, 2023
·
1 min read
Business

Amicus Therapeutics to Announce First Quarter 2023 Financial Results on May 10, 2023

Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Wednesday, May 10, 2023, at 8:30 a.m. ET to discuss financial results for the first quarter ended March 31, 2023.

May 1, 2023
·
1 min read